Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$46,854,500
+$685,666 QoQ
Shares Held
550,000
-21.5% QoQ
Ownership
0.396%
of shares outstanding
% of Portfolio
2.36%
of 13F equity value
Holder Rank
#54
of 477 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. CYTK ranks #11 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
3,750,000 | $132,712,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
987,000 | $131,004,510 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $113,561,516 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
1,595,000 | $96,274,200 | |
| 5 | ERAS |
Erasca, Inc.
|
5,250,000 | $96,180,000 | |
| 6 | INSM |
INSMED Inc
|
650,000 | $69,303,000 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
185,000 | $61,936,150 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
590,000 | $56,150,300 |
All Filings in CYTK
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,854,500 | 550,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $46,168,834 | 700,483 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $50,832,000 | 800,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,236,000 | 350,000 | Shares | Sole | 2025-11-13 | |
| 2024-03-31 | $5,608,800 | 80,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $13,358,400 | 160,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,786,582 | 230,366 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,082,327 | 125,148 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $7,793,282 | 221,463 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,013,877 | 87,601 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,149,250 | 65,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $589,350 | 15,000 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $6,634,260 | 145,552 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,467,500 | 125,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,385,300 | 70,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $930,400 | 40,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,454,600 | 70,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||